Mechanisms for the antihyperglycemic effect of sitagliptin in patients with type 2 diabetes
Research output: Contribution to journal › Journal article › Research › peer-review
Dipeptidyl peptidase IV (DPP-4) inhibitors improve glycemic control in patients with type 2 diabetes. The underlying mechanisms (incretin effect, β-cell function, endogenous glucose production) are not well known.
| Original language | English |
|---|---|
| Journal | Journal of Clinical Endocrinology and Metabolism |
| Volume | 97 |
| Issue number | 8 |
| Pages (from-to) | 2818-26 |
| Number of pages | 9 |
| ISSN | 0021-972X |
| DOIs | |
| Publication status | Published - Aug 2012 |
- Adult, Aged, Blood Glucose, Diabetes Mellitus, Type 2, Double-Blind Method, Female, Glucagon, Glucagon-Like Peptide 1, Humans, Hypoglycemic Agents, Insulin-Secreting Cells, Male, Middle Aged, Pyrazines, Triazoles
Research areas
ID: 45841132